Table 2 Baseline characteristics and comorbidities of elderly patients who underwent endoscopic resection
Variables | ||
|---|---|---|
Age, yrs., mean ± SD | 78.7 ± 3.2 | |
Female sex, n (%) | 101 (41.7) | |
Body mass index, kg/m2, mean ± SD | 23.7 ± 3.3 | |
Comorbidities, variable CCI, n (%) | Weighting | |
Acute myocardial infarction | 1 | 30 (12.4) |
Congestive heart failure | 1 | 11 (4.5) |
Peripheral vascular disease | 1 | 3 (1.2) |
Cerebrovascular accident | 1 | 11 (4.5) |
Dementia | 1 | 5 (2.1) |
Chronic pulmonary disease | 1 | 27 (11.2) |
Connective tissue disease | 1 | 0 (0) |
Ulcer disease | 1 | 0 (0) |
Mild liver disease | 1 | 13 (5.4) |
Hepatitis | 8 (3.3) | |
Diabetes | 1 | 56 (23.1) |
Diabetes with end organ damage | 2 | 0 (0) |
Hemiplegia | 2 | 0 (0) |
Moderate or severe renal disease | 2 | 3 (1.2) |
Any tumor | 2 | 31 (12.8) |
Leukemia | 2 | 0 (0) |
Lymphoma | 2 | 0 (0) |
Moderate to severe liver disease | 3 | 5 (2.1) |
Metastatic solid tumor | 6 | 0 (0) |
Acquired immunodeficiency syndrome | 6 | 0 (0) |
Charlson comorbidity index, mean ± SD | 1.67 ± 1.43 | |
ASA-PS, mean ± SD | 2.01 ± 0.49 | |
ECOG-PS, mean ± SD | 1.55 ± 0.55 | |
Medication, n (%) | ||
Aspirin | 70 (28.9) | |
Clopidogrel | 10 (4.1) | |
Antithrombotic agents | 1 (0.4) | |